# Seven Constitutional Axioms (Pharma Domain)
## Immutable Constitutional Constraints for Pharmaceutical Reproducibility

These seven axioms are the irreducible constitutional foundation of the Pharma
Domain. They are immutable. Any pharmaceutical process that violates any axiom
shall not be recognized as reproducible under this standard.

Normative reference:  
Russell, “Constitutional Mathematics for Pharmaceutical Reproducibility”
(SSRN‑6816078, May 22, 2026)

---

## Axiom I — Reproducibility Requires Determinism

A pharmaceutical entity \(Y \in \mathcal{E}\) is reproducible if and only if its
constitutional mapping \(M(Y)\) is deterministic.

WAD Constraint:  
Reproducible(\(Y\)) ⇒ \(M(Y)\) deterministic

Regulatory Basis: ICH Q10; FDA cGMP

---

## Axiom II — Determinism Requires Fixed‑Point Membership

The constitutional mapping \(M\) is deterministic if and only if \(Y\) converges
to a fixed point in the 27‑component basis \(F_{27}\).

WAD Constraint:  
\(M\) deterministic ⇒ \(Y \in F_{27}\)

Regulatory Basis: ICH Q6A; BCS

---

## Axiom III — Fixed‑Point Membership Requires Full Component Verification

A pharmaceutical entity \(Y\) is a member of \(F_{27}\) if and only if all 27
components \(C_1 \dots C_{27}\) satisfy their validation thresholds:

\[
\forall i \in \{1,\dots,27\}: V_i(Y) \ge \theta_i
\]

Nominal threshold: \(\theta_i = 0.95\)

Regulatory Basis: ICH Q6A/Q6B

---

## Axiom IV — Verification Requires Machine Audit

Verification of any component \(C_i\) requires a machine‑generated audit entry
audit\(_i \in \mathcal{L}\) in the cryptographic ledger.

Human attestation alone is insufficient.

WAD Constraint:  
Verified(\(C_i\)) ⇒ audit\(_i \in \mathcal{L}\)

Regulatory Basis: ICH Q9; ISO/IEC 17025

---

## Axiom V — Machine Audit Requires Ledger Anchoring

Machine audit requires cryptographic ledger anchoring of the state hash
\(H(Y_k)\) at every refinement step \(k\).

WAD Constraint:  
audit\(_i \in \mathcal{L}\) ⇒ \(H(Y_k)\) anchored

Regulatory Basis: IEEE 2418

---

## Axiom VI — Purity Gate

No pharmaceutical entity shall be classified as purified unless its impurity
fraction, measured by HPLC‑MS, satisfies:

\[
imp(Y) < 0.1\%
\]

WAD Constraint:  
Purified(\(Y\)) ⇒ imp(\(Y\)) < 0.1%

Regulatory Basis: ICH Q3A(R2)

---

## Axiom VII — Gas Convergence

No refinement pass \(k\) shall be accepted as constitutionally valid unless the
gas usage \(Gas_k\) on the designated ledger network satisfies:

\[
Gas_k \in
